Impact of the COVID-19 Pandemic on Parkinson's Disease and Movement Disorders

Affiliations

¹ Yerkes National Primate Research Center, Department of Neurology Emory University School of Medicine Atlanta Georgia USA.
² Van Andel Institute, Center for Neurodegenerative Science Grand Rapids Michigan USA.
³ Movement Disorders Unit, Department of Neurology Westmead Hospital and Sydney Medical School, University of Sydney Sydney NSW Australia.
⁴ Department of Neurology New York University Grossman School of Medicine New York New York USA.
⁵ Department of Medical Sciences Newcastle University Medical School Newcastle United Kingdom.
⁶ Department of Neurology Santa Maria University Hospital Terni Italy.
⁷ Department of Neurology Neurological Institute, Taipei Veterans General Hospital Taipei Taiwan.
⁸ Department of Neurology Columbia University Irving Medical Center New York New York USA.
⁹ Paracelsus-Elena Klinik, Kassel, Department of Neurosurgery University Medical Center Goettingen Goettingen Germany.

Stella M Papa et al. Mov Disord Clin Pract. 2020.

. 2020 Apr 16;7(4):357-360.

doi: 10.1002/mdc3.12953. eCollection 2020 May.

¹ Yerkes National Primate Research Center, Department of Neurology Emory University School of Medicine Atlanta Georgia USA.
² Van Andel Institute, Center for Neurodegenerative Science Grand Rapids Michigan USA.
³ Movement Disorders Unit, Department of Neurology Westmead Hospital and Sydney Medical School, University of Sydney Sydney NSW Australia.
⁴ Department of Neurology New York University Grossman School of Medicine New York New York USA.
⁵ Department of Medical Sciences Newcastle University Medical School Newcastle United Kingdom.
⁶ Department of Neurology Santa Maria University Hospital Terni Italy.
⁷ Department of Neurology Neurological Institute, Taipei Veterans General Hospital Taipei Taiwan.
⁸ Department of Neurology Columbia University Irving Medical Center New York New York USA.
⁹ Paracelsus-Elena Klinik, Kassel, Department of Neurosurgery University Medical Center Goettingen Goettingen Germany.

No abstract available

Keywords: COVID‐19; Parkinson's disease; SARS‐CoV‐2; coronavirus; movement disorders; pandemic.

Conflict of interest statement

The authors report no sources of funding and no conflicts of interest.

1. Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395:565–574. - PMC - PubMed
1. Coronaviridae Study Group of the International Committee on Taxonomy of viruses . The species Severe acute respiratory syndrome‐related coronavirus: classifying 2019‐nCoV and naming it SARS‐CoV‐2. Nat Microbiol 2020;5:536–544. - PMC - PubMed
1. Pan Y, Zhang D, Yang P, Poon LLM, Wang Q. Viral load of SARS‐CoV‐2 in clinical samples. Lancet Infect Dis 2020;20:411–412. - PMC - PubMed
1. Zou L, Ruan F, Huang M, et al. SARS‐CoV‐2 viral load in upper respiratory specimens of infected patients. N Engl J Med 2020;382:1177–1179. - PMC - PubMed
1. Bai Y, Yao L, Wei T, et al. Presumed asymptomatic carrier transmission of COVID‐19. JAMA 2020. Feb 21. 10.1001/jama.2020.2565. [Epub ahead of print] - DOI - PMC - PubMed